By Deena Beasley Nov 5 (Reuters) – A trial of Pfizer Inc’s experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday. The results appear to surpass those seen with Merck & Co Inc’s pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for COVID-19 patients also at high risk of serious… Source link
Read More »Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector
By Lewis Krauskopf and Manojna Maddipatla (Reuters) – Positive clinical trial results for Merck & Co’s experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker’s stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies. Merck shares jumped as much as 12.3% and hit their highest level since February 2020 after data showed the company’s pill molnupiravir… Source link
Read More »Facebook and Google condemned over ads for ‘abortion pill reversal’ | Abortion
Facebook has served “abortion reversal” adverts 18.4m times since January 2020, according to a report from the Center for Countering Digital Hate (CCDH), promoting an “unproven, unethical” and “dangerous” procedure. Google shows the adverts on more than four-fifths of searches related to abortion across a number of US cities, according to the CCDH research, targeted at search terms such as “unwanted pregnancy” and “abortion pill”. The adverts promote an unproven theoretical… Source link
Read More »